Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment DOI Creative Commons
Fengrui Liu, Senlin Li,

Chengcheng Huang

et al.

RSC Advances, Journal Year: 2025, Volume and Issue: 15(15), P. 11675 - 11687

Published: Jan. 1, 2025

We developed a glutathione (GSH) responsive nanoplatform for the co-delivery of sorafenib (Sor) and brusatol (Bru). This enhanced Bru’s efficacy increased Sor’s sensitivity. innovative approach effectiveness in hepatocellular carcinoma (HCC) treatment.

Language: Английский

Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment DOI Creative Commons
Fengrui Liu, Senlin Li,

Chengcheng Huang

et al.

RSC Advances, Journal Year: 2025, Volume and Issue: 15(15), P. 11675 - 11687

Published: Jan. 1, 2025

We developed a glutathione (GSH) responsive nanoplatform for the co-delivery of sorafenib (Sor) and brusatol (Bru). This enhanced Bru’s efficacy increased Sor’s sensitivity. innovative approach effectiveness in hepatocellular carcinoma (HCC) treatment.

Language: Английский

Citations

0